Copyright Reports & Markets. All rights reserved.

Global Acute Otitis Media Treatment Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Acute Otitis Media Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Acute Otitis Media Treatment Market Size Growth Rate by Product
      • 1.4.2 Antibiotics
      • 1.4.3 Nonsteroidal anti-Inflammatory drug
      • 1.4.4 Analgesic
      • 1.4.5 Anaesthetic
    • 1.5 Market by End User
      • 1.5.1 Global Acute Otitis Media Treatment Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Retail pharmacies
      • 1.5.4 Online pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Acute Otitis Media Treatment Market Size
      • 2.1.1 Global Acute Otitis Media Treatment Revenue 2014-2025
      • 2.1.2 Global Acute Otitis Media Treatment Sales 2014-2025
    • 2.2 Acute Otitis Media Treatment Growth Rate by Regions
      • 2.2.1 Global Acute Otitis Media Treatment Sales by Regions
      • 2.2.2 Global Acute Otitis Media Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Acute Otitis Media Treatment Sales by Manufacturers
      • 3.1.1 Acute Otitis Media Treatment Sales by Manufacturers
      • 3.1.2 Acute Otitis Media Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Acute Otitis Media Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Acute Otitis Media Treatment Revenue by Manufacturers
      • 3.2.1 Acute Otitis Media Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Acute Otitis Media Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Acute Otitis Media Treatment Price by Manufacturers
    • 3.4 Acute Otitis Media Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Acute Otitis Media Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Acute Otitis Media Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Acute Otitis Media Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Acute Otitis Media Treatment Sales by Product
    • 4.2 Global Acute Otitis Media Treatment Revenue by Product
    • 4.3 Acute Otitis Media Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Acute Otitis Media Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Acute Otitis Media Treatment by Countries
      • 6.1.1 North America Acute Otitis Media Treatment Sales by Countries
      • 6.1.2 North America Acute Otitis Media Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Acute Otitis Media Treatment by Product
    • 6.3 North America Acute Otitis Media Treatment by End User

    7 Europe

    • 7.1 Europe Acute Otitis Media Treatment by Countries
      • 7.1.1 Europe Acute Otitis Media Treatment Sales by Countries
      • 7.1.2 Europe Acute Otitis Media Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Acute Otitis Media Treatment by Product
    • 7.3 Europe Acute Otitis Media Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Acute Otitis Media Treatment by Countries
      • 8.1.1 Asia Pacific Acute Otitis Media Treatment Sales by Countries
      • 8.1.2 Asia Pacific Acute Otitis Media Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Acute Otitis Media Treatment by Product
    • 8.3 Asia Pacific Acute Otitis Media Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Acute Otitis Media Treatment by Countries
      • 9.1.1 Central & South America Acute Otitis Media Treatment Sales by Countries
      • 9.1.2 Central & South America Acute Otitis Media Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Acute Otitis Media Treatment by Product
    • 9.3 Central & South America Acute Otitis Media Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Acute Otitis Media Treatment by Countries
      • 10.1.1 Middle East and Africa Acute Otitis Media Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Acute Otitis Media Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Acute Otitis Media Treatment by Product
    • 10.3 Middle East and Africa Acute Otitis Media Treatment by End User

    11 Company Profiles

    • 11.1 Pfizer, Inc
      • 11.1.1 Pfizer, Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Pfizer, Inc Acute Otitis Media Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Pfizer, Inc Acute Otitis Media Treatment Products Offered
      • 11.1.5 Pfizer, Inc Recent Development
    • 11.2 Eli Lilly and Company
      • 11.2.1 Eli Lilly and Company Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Eli Lilly and Company Acute Otitis Media Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Eli Lilly and Company Acute Otitis Media Treatment Products Offered
      • 11.2.5 Eli Lilly and Company Recent Development
    • 11.3 Abbott Laboratories
      • 11.3.1 Abbott Laboratories Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Abbott Laboratories Acute Otitis Media Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Abbott Laboratories Acute Otitis Media Treatment Products Offered
      • 11.3.5 Abbott Laboratories Recent Development
    • 11.4 GlaxoSmithKline plc
      • 11.4.1 GlaxoSmithKline plc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 GlaxoSmithKline plc Acute Otitis Media Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 GlaxoSmithKline plc Acute Otitis Media Treatment Products Offered
      • 11.4.5 GlaxoSmithKline plc Recent Development
    • 11.5 Bayer AG
      • 11.5.1 Bayer AG Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Bayer AG Acute Otitis Media Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Bayer AG Acute Otitis Media Treatment Products Offered
      • 11.5.5 Bayer AG Recent Development
    • 11.6 Novartis AG
      • 11.6.1 Novartis AG Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Novartis AG Acute Otitis Media Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Novartis AG Acute Otitis Media Treatment Products Offered
      • 11.6.5 Novartis AG Recent Development
    • 11.7 Pediapharm Inc
      • 11.7.1 Pediapharm Inc Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Pediapharm Inc Acute Otitis Media Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Pediapharm Inc Acute Otitis Media Treatment Products Offered
      • 11.7.5 Pediapharm Inc Recent Development
    • 11.8 Sanofi S.A
      • 11.8.1 Sanofi S.A Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Sanofi S.A Acute Otitis Media Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Sanofi S.A Acute Otitis Media Treatment Products Offered
      • 11.8.5 Sanofi S.A Recent Development
    • 11.9 Bristol Myers Squibb Company
      • 11.9.1 Bristol Myers Squibb Company Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Bristol Myers Squibb Company Acute Otitis Media Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Bristol Myers Squibb Company Acute Otitis Media Treatment Products Offered
      • 11.9.5 Bristol Myers Squibb Company Recent Development

    12 Future Forecast

    • 12.1 Acute Otitis Media Treatment Market Forecast by Regions
      • 12.1.1 Global Acute Otitis Media Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Acute Otitis Media Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Acute Otitis Media Treatment Market Forecast by Product
      • 12.2.1 Global Acute Otitis Media Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Acute Otitis Media Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Acute Otitis Media Treatment Market Forecast by End User
    • 12.4 North America Acute Otitis Media Treatment Forecast
    • 12.5 Europe Acute Otitis Media Treatment Forecast
    • 12.6 Asia Pacific Acute Otitis Media Treatment Forecast
    • 12.7 Central & South America Acute Otitis Media Treatment Forecast
    • 12.8 Middle East and Africa Acute Otitis Media Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Acute Otitis Media Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Acute otitis media (AOM) is a type of ear infection in which air-filled space behind the eardrum (the middle ear) is infected and causes pain and general symptoms of illness such as fever, irritability and problem in sleeping.
      The global Acute Otitis Media Treatment market is valued at 2040 million US$ in 2018 and will reach 3010 million US$ by the end of 2025, growing at a CAGR of 5.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Acute Otitis Media Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Acute Otitis Media Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Acute Otitis Media Treatment in these regions.
      This research report categorizes the global Acute Otitis Media Treatment market by top players/brands, region, type and end user. This report also studies the global Acute Otitis Media Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Pfizer, Inc
      Eli Lilly and Company
      Abbott Laboratories
      GlaxoSmithKline plc
      Bayer AG
      Novartis AG
      Pediapharm Inc
      Sanofi S.A
      Bristol Myers Squibb Company

      Market size by Product
      Antibiotics
      Nonsteroidal anti-Inflammatory drug
      Analgesic
      Anaesthetic
      Market size by End User
      Hospitals
      Retail pharmacies
      Online pharmacies

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Acute Otitis Media Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Acute Otitis Media Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Acute Otitis Media Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Acute Otitis Media Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Acute Otitis Media Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Acute Otitis Media Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now